-
Pfizer, BioNTech get US FDA nod for emergency use of COVID-19 vaccine in adolescents
expresspharma
May 12, 2021
Pfizer and BioNTech SE announced that the US Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for their COVID-19 vaccine to include individuals 12 to 15 years of age.
-
Novavax postpones timelines for COVID-19 vaccine production, regulatory authorisations
expresspharma
May 12, 2021
The company has repeatedly pushed back production forecasts and has struggled to access raw materials and equipment needed to make its vaccine.
-
Pfizer and BioNTech to provide COVID-19 vaccine doses for olympic athletes at the 2020 Tokyo Games
worldpharmanews
May 11, 2021
Pfizer Inc. and BioNTech SE announced the signing of a Memorandum of Understanding (MoU) with the International Olympic Committee (IOC) to donate doses of the companies' COVID-19 Vaccine to help vaccinate athletes, and their delegations, participating ...
-
Novavax Announces positive preclinical data for combination influenza and COVID-19 vaccine candidate
worldpharmanews
May 11, 2021
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced data from a preclinical study of the company's combination quadrivalent seasonal flu vaccine (NanoFlu™) and COVID-19 vaccine candidate.
-
WHO grants Sinopharm’s COVID-19 vaccine emergency approval
pharmatimes
May 11, 2021
The World Health Organization (WHO) has approved Sinopharm’s COVID-19 vaccine for emergency use, making it the first jab developed by a non-Western company to gain this recommendation.
-
Bharat Biotech begins direct supply of COVAXIN to 14 states
expresspharma
May 11, 2021
The firm has started supplying its COVID-19 vaccine to the states based on the allocations received by the central government.
-
Biological E. to begin Phase III trial of COVID-19 vaccine
expresspharma
May 10, 2021
Biological E. will soon start Phase III trials of its COVID-19 vaccine and plans to produce 75 million to 80 million doses a month from August, its managing director told Reuters.
-
Tech transfers, collaborations, materials supply key to scale up vaccine manufacturing: Suchitra Ella
expresspharma
May 10, 2021
Bharat Biotech is in the process of ramping up the manufacturing capacity of Covaxin to 70 crore dosages per annum.
-
COVID Vaccine-Hesitant Consumers Care About Effectiveness Over Side-Effects
prnewswire
May 08, 2021
Market research software company Conjoint.ly released results from its recent Consumer Preferences for COVID-19 Vaccine conjoint analysis survey, revealing that vaccine-hesitant consumers in the UK and US are most likely to be swayed by ...
-
Over 120 countries back IP rights waiver on Covid-19 vaccines
pharmaceutical-technology
May 08, 2021
In October last year, India and South Africa had floated the proposal to waive IP rights at the World Trade Organization’s (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council to waive such protections of the agreement for some ...